SCHEMBL208312

SCHEMBL208312

CCOCC(COCC)OCC

nearest known ligand 0.42

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.42
LMNA P02545 1/20 0.40
LPAR1 Q92633 4/20 0.31
LPAR3 Q9UBY5 4/20 0.31
LPAR2 Q9HBW0 1/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10023016 0.97 THRB (0.40) THRBLMNA
SCHEMBL11955576 0.97 THRB (0.40) THRBLMNA
SCHEMBL12413966 0.89 THRB (0.35) THRBLMNA
SCHEMBL242883 0.88 THRB (0.38) THRBLMNA
SCHEMBL13524899 0.87 ALDH1A1 (0.35) THRBLMNALPAR1LPAR3LPAR2
Water SCHEMBL4365142 0.86 THRB (0.36) THRBLMNA
SCHEMBL13024100 0.85 KDM4E (0.40) THRBLMNAALDH1A1
SCHEMBL9575312 0.85 THRB (0.33) THRBLMNA
SCHEMBL9602518 0.84 THRB (0.35) THRBLMNALPAR1LPAR3LPAR2
SCHEMBL304955 0.84 ALDH1A1 (0.36) THRBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238251-A9 A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof ASCENTAGE PHARMA (SUZHOU) CO., LTD. (CN) 2024-07-18 US claimed
CN-114929844-B Nitrate esters of ethers of glycerol and ethanol as diesel cetane improvers and process for producing the same 巴西石油公司 2024-06-18 CN claimed
CN-115043711-B Preparation method of perfluoro-n-propyl vinyl ether 三明市海斯福化工有限责任公司 2024-02-09 CN claimed
US-20230404909-A1 MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN LEO PHARMA AS (DK) 2023-12-21 US claimed
US-11845038-B2 Reducing acid gases from streams THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2023-12-19 US claimed
US-20230390245-A1 A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof SHANGHAI YASHENG PHARMACEUTICAL TECH CO LTD (CN) 2023-12-07 US claimed
CN-116799213-A Lithium ion battery positive electrode slurry dispersion auxiliary agent and preparation method and application thereof 江西安驰新能源科技有限公司 2023-09-22 CN claimed
EP-4240330-A1 A COMPOSITION COMPRISING HETEROCYCLIC COMPOUNDS, PREPARATION METHOD AND APPLICATION THEREOF Shanghai Yasheng Pharmaceutical Technology Co., Ltd. (CN) 2023-09-13 EP claimed
US-20220401877-A1 REDUCING ACID GASES FROM STREAMS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA 2022-12-22 US claimed
US-11452969-B2 Reducing acid gases from streams THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2022-09-27 US claimed
EP-2767266-A1 Wound care product made from bulked filament tow Celanese Acetate LLC (US) 2014-08-20 EP claimed
US-8734541-B2 Diesel fuel formulation SHELL OIL COMPANY (US) 2014-05-27 US claimed
EP-2081527-B1 WOUND CARE PRODUCT MADE FROM BULKED FILAMENT TOW CELANESE ACETATE LLC (US) 2014-03-19 EP claimed
US-20120145106-A1 DIESEL FUEL FORMULATION SHELL OIL COMPANY (US) 2012-06-14 US claimed
EP-2081527-A1 WOUND CARE PRODUCT MADE FROM BULKED FILAMENT TOW Celanese Acetate LLC (US) 2009-07-29 EP claimed
WO-2008060306-A1 WOUND CARE PRODUCT MADE FROM BULKED FILAMENT TOW CELANESE ACETATE LLC (US) 2008-05-22 WO claimed
US-20080113574-A1 WOUND CARE PRODUCT MADE FROM BULKED FILAMENT TOW DEUTSCHE BANK AG, NEW YORK BRANCH, AS COLLATERAL AGENT 2008-05-15 US claimed
EP-0998912-B1 Use of peracids for hand's disinfection or decontamination BODE CHEMIE GMBH & CO (DE) 2004-10-20 EP claimed
EP-0998912-A1 Agent for quick decontamination and disinfection of the skin and hands Bode Chemie GmbH & Co. (DE) 2000-05-10 EP claimed
US-H1565-H Superabsorbent, continuous filament web DEUTSCHE BANK AG, NEW YORK BRANCH 1996-07-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230390245-A1 A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof ABCG2, AP1G1, ALPI THRB 4853/4885LMNA 2555/4885LPAR1 1850/4885
US-20230404909-A1 MICRONEEDLE PATCH FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN MMP1, MMP17, CUTA THRB 539/4885LMNA 2876/4885LPAR1 995/4885
US-20240238251-A9 A Composition Comprising Heterocyclic Compounds, Preparation Method and Application Thereof ABCG2, AP1G1, ALPI THRB 4853/4885LMNA 2555/4885LPAR1 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.